Tackling the threat of drug-resistant E. coli in China
A comprehensive seven-year study across 20 Chinese provinces has revealed a concerning rise in antimicrobial resistance (AMR) ...
Expert: E. coli infection among doctors at Hong Kong hospital ‘unlikely to spread widely’
An E coli infection linked to the death of a doctor in Princess Margaret Hospital is unlikely to lead to widespread ...
Scientists develop magnesium-enriched nanofiber patches for safer wound healing
The skin serves as the body's primary defense against harmful microorganisms, toxins, and physical damage. However, severe ...
GEN1d
Antibiotic Resistance Linked to Extra Pump Proteins in Gram-Negative Bacteria
By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in antibiotic resistance.
Food Safety News7d
Publisher’s Platform: Combating E. coli — A call for vigilance in food safety practices
Escherichia coli, commonly known as E. coli, is a versatile bacterium. While many strains are harmless and a natural part of our intestinal ...
Nature3d
A bacterial antiviral system detects and directly fights against infection
Protein complex in bacterial cell membrane acts like a rotary motor to recruit DNA-degrading enzymes to defend against phage ...
Bacterial species study challenges assumption that structural similarity predicts protein behavior
A new study published in Biochemistry sheds light on how bacteria regulate their genes, challenging long-held assumptions ...
香港政府新聞網3d
Suspected E. coli cluster probed
The Centre for Health Protection is looking into a suspected Shiga toxin-producing Escherichia coli infection cluster ...
Renal & Urology News1d
Emblaveo Approved for Intra-Abdominal Infections in Patients With Limited Options
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
AbbVie says FDA approves Emblaveo in combination with metronidazole in adults
AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...
J&J to discontinue E.coli vaccine candidate study
Johnson & Johnson said on Thursday it will discontinue a late-stage study of an experimental E.coli vaccine it was developing in partnership with Sanofi. The drugmaker said its decision was based on t ...